FY2027 EPS Estimates for Ardelyx, Inc. (NASDAQ:ARDX) Reduced by HC Wainwright

Ardelyx, Inc. (NASDAQ:ARDX – Free Report) – Investment analysts at HC Wainwright reduced their FY2027 earnings per share (EPS) estimates for shares of Ardelyx in a report released on Monday, August 5th. HC Wainwright analyst E. Arce now forecasts that the biopharmaceutical company will earn $1.31 per share for the year, down from their previous […]

Leave a Reply

Your email address will not be published.

Previous post Akari Therapeutics (NASDAQ:AKTX) Now Covered by StockNews.com
Next post Secrets of Success: Insights from Camilla Hadcock, Director of Roach Bridge Tissues